Evidence map›Paper›PMID 26264452›Full record

Observational studyLiver international : official journal of the International Association for the Study of the Liver2016

Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.

Simone Lanini, Alessandro Nanni Costa, Paolo A Grossi, Francesco Procaccio, Andrea Ricci, Maria R Capobianchi, Norah A Terrault, Giuseppe Ippolito

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Liver international : official journal of the International Association for the Study of the Liver, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Sex Drives Dimorphic Immune Responses to Viral Infections.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Simone Lanini'Lazzaro Spallanzani' National Institute for Infectious Diseases IRCCS, Rome, Italy.
Alessandro Nanni CostaItalian National Transplant Center (CNT), Italian National Institute of Health (ISS), Rome, Italy.
Paolo A GrossiDepartment of Surgical and Morphological Sciences, University of Insubria-Ospedale di Circolo, Varese, Italy.
Francesco ProcaccioItalian National Transplant Center (CNT), Italian National Institute of Health (ISS), Rome, Italy.
Andrea RicciItalian National Transplant Center (CNT), Italian National Institute of Health (ISS), Rome, Italy.
Maria R Capobianchi'Lazzaro Spallanzani' National Institute for Infectious Diseases IRCCS, Rome, Italy.
Norah A TerraultUniversity of California San Francisco, San Francisco, CA, USA.
Giuseppe Ippolito'Lazzaro Spallanzani' National Institute for Infectious Diseases IRCCS, Rome, Italy.
National Institute of Statistics · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of California, San Francisco · USUniversity of Insubria · IT

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

BACKGROUND AND

aimsIn patients with hepatitis C virus (HCV), recurrence of infection after liver transplant (LT) is universal and associated with worst survival. We present the results of an Italian cohort to compare the 3-year outcome of HCV-Ab-positive and HCV-Ab-negative LT recipients and to assess the potential interaction between HCV-Ab sero-status and other risk factors for LT failure.

methodsThe study is a multicentre cohort including a sample of liver transplant centres. Participant's information was collected at the local level. The best functional form of variables was decided according to the objective methods based on information theory. Association between transplant failure and potential risk factors was assessed in univariate and multivariate Poisson regression model with random intercept.

resultsBetween June 2007 and May 2009, 1164 LT recipients were enrolled in 16 Italian transplant centres, of them 275 (23.63%) experienced LT failure. Incidence rates of LT failure was 0.32 and 0.23 per 1000 person-days in HCV-Ab-positive and HCV-Ab-negative recipients respectively (P = 0.003). Inferential models according to Akaike information criterion indicated that donor-recipient age difference and donor-recipient sex matching were more informative to predict LT failure than the age and the sex as separate variables. Multivariate analysis provided evidence that HCV-Ab sero-status, time after LT, donor-recipient age difference, donor-recipient sex matching and recipient's MELD score were significantly associated with LT failure. Moreover, the effect of HCV-Ab sero-status on LT failure was modified by the simultaneous action of time after LT and donor-recipient age difference. No interaction was found between recipient's HCV-Ab sero-status and either recipient's MELD or donor-recipient sex matching.

conclusionIn view of the imminent introduction of new anti-HCV therapies, our study provides information to assess which LT recipients should be prioritized for receiving these highly effective, but expensive, new treatments. This is particularly relevant for those clinical settings where healthcare prioritization is endorsed by national authorities.

Indexed as

Patient SelectionVirus ActivationAntiviral AgentsBiomarkersCohort StudiesEnd Stage Liver DiseaseFemaleHealth PrioritiesHepacivirusHepatitis CHepatitis C AntibodiesHumansItalyLiver TransplantationMaleMultivariate AnalysisAntiviral AgentsBiomarkersHepatitis C AntibodiesDonor-recipient age differencedonor-recipient sex matchingliver graft failureMELD scoremulticentre study

Identifiers

PMID26264452
PMCPMC5317090
OpenAlexW1961629264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.